These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7041324)

  • 1. Carbimazole and exercise tolerance in chronic airflow obstruction.
    Butland RJ; Pang JA; Geddes DM
    Thorax; 1982 Jan; 37(1):64-7. PubMed ID: 7041324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breathlessness and exercise tolerance in chronic airflow obstruction: 2-hourly versus 4-hourly salbutamol by inhalation.
    Shah SS; Johnston D; Woodcock AA; Johnson M; Geddes DM
    Curr Med Res Opin; 1983; 8(5):345-9. PubMed ID: 6340975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to oral corticosteroids in chronic airflow obstruction.
    Lam WK; So SY; Yu DY
    Br J Dis Chest; 1983 Apr; 77(2):189-98. PubMed ID: 6347233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between oxygen consumption and work rate in patients with airflow obstruction.
    Lewis MI; Belman MJ; Monn SA; Elashoff JD; Koerner SK
    Chest; 1994 Aug; 106(2):366-72. PubMed ID: 7774304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin and perception of dyspnea in chronic airflow obstruction.
    Schiffman GL; Stansbury DW; Fischer CE; Sato RI; Light RW; Brown SE
    Am Rev Respir Dis; 1988 May; 137(5):1094-8. PubMed ID: 3195807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.
    Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM
    Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary responses to exercise in chronic airflow obstruction. Effects of inhaled atropine sulfate.
    Brown SE; Prager RS; Shinto RA; Fischer CE; Stansbury DW; Light RW
    Chest; 1986 Jan; 89(1):7-11. PubMed ID: 3940792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.
    Wijkstra PJ; TenVergert EM; van der Mark TW; Postma DS; Van Altena R; Kraan J; Koëter GH
    Thorax; 1994 May; 49(5):468-72. PubMed ID: 8016768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation.
    Mitchell DM; Gildeh P; Dimond AH; Collins JV
    Thorax; 1986 Aug; 41(8):606-10. PubMed ID: 3538487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrocodeine for breathlessness in "pink puffers".
    Johnson MA; Woodcock AA; Geddes DM
    Br Med J (Clin Res Ed); 1983 Feb; 286(6366):675-7. PubMed ID: 6402199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Willan A; Cook D; Harper S; Morris J; Ramsdale H; Haddon R; Newhouse M
    Thorax; 1994 May; 49(5):479-84. PubMed ID: 8016770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease.
    Grove A; Lipworth BJ; Reid P; Smith RP; Ramage L; Ingram CG; Jenkins RJ; Winter JH; Dhillon DP
    Thorax; 1996 Jul; 51(7):689-93. PubMed ID: 8882074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eimer M; Cable T; Gal P; Rothenberger LA; McCue JD
    J Fam Pract; 1985 Nov; 21(5):359-62. PubMed ID: 2865326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome.
    Eiser N; Denman WT; West C; Luce P
    Eur Respir J; 1991 Sep; 4(8):926-31. PubMed ID: 1783082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.
    Weir DC; Burge PS
    Thorax; 1993 Apr; 48(4):309-16. PubMed ID: 8511727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between six-minute walking test and pulmonary function and ventilatory drive in patients with airflow limitation.
    Chiang LL; Ho SC; Cheng HF; Sheng DF; Lin HC; Kuo HP
    Chang Gung Med J; 2001 Mar; 24(3):159-66. PubMed ID: 11355083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of theophylline on exercise performance in patients with severe chronic obstructive pulmonary disease.
    Fink G; Kaye C; Sulkes J; Gabbay U; Spitzer SA
    Thorax; 1994 Apr; 49(4):332-4. PubMed ID: 8202902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema.
    Butland RJ; Pang JA; Geddes DM
    J Appl Physiol Respir Environ Exerc Physiol; 1983 May; 54(5):1368-73. PubMed ID: 6863097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.